Bonsai Health | $7,000,000 | (Sep 26, 2025)
Irregular (formerly Pattern Labs) | $80,000,000 | (Sep 26, 2025)
Scorecard | $3,750,000 | (Sep 26, 2025)
Certified by Founder
Lodge
Psylo
start up
Australia
- Sydney, NSW
- 04/06/2024
- Seed
- $8,000,000
Psylo is a drug development company focused on next generation psychedelics; our goal is to make broadly accessible medicines as improved treatments to currently available SSRI medications, using psychedelic molecules as the starting point. We are building a pipeline of novel molecules with the ultimate goal of taking leading candidates through to clinical trials.
- Industry Biotechnology
- Website https://psylo.bio/
- LinkedIn https://www.linkedin.com/company/psylo/
Juicebox | $36,000,000 | (Sep 26, 2025)
SocialPost.ai | $1,000,000 | (Sep 26, 2025)
BURNT | $3,800,000 | (Sep 26, 2025)
Axon Therapies Inc. | $32,000,000 | (Sep 26, 2025)
Factory(US) | $50,000,000 | (Sep 26, 2025)
Ardent AI | $2,150,000 | (Sep 26, 2025)
Alguna | $4,000,000 | (Sep 26, 2025)
SEON | $80,000,000 | (Sep 26, 2025)
Trismik | $2,936,967 | (Sep 26, 2025)